Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

National Health Education Campaign: "When Will You Pick?"™ Encourages Families to Make Flu Vaccination a Priority This Fall

September 21, 2010 9:32 am | by Bio-Medicine.Org | News | Comments

GAITHERSBURG, Md., Sept. 21 /- New school schedules, exciting sporting events, and daily homework assignments are already keeping families busy this fall. But how many have taken time to get their annual flu vaccinations? The U.S. Centers for Disease Control and Prevention (CDC) advises...

TOPICS:

Pittsburgh Life Sciences Greenhouse Executive-in-Residence Launches Medical Device Company

September 21, 2010 9:32 am | by Bio-Medicine.Org | News | Comments

PITTSBURGH, Sept. 21 /- The Pittsburgh Life Sciences Greenhouse (PLSG), the organization providing capital investments and customized company formation and business growth programs to western Pennsylvania's life sciences enterprises, announced today that one of its nationally recognized...

TOPICS:

Class I Medical Device Recall: Symbiq One and Two-Channel Infusers

September 21, 2010 8:32 am | by U.S. Food & Drug Administration | News | Comments

Reason for Recall: There is potential for unrestricted flow of fluid or medication if the administration set (cassette) is removed before the cassette carriage fully opens and the slide/roller clamp is not closed. Additionally, when unrestricted flow...

Advertisement

Partnership between Elekta and INFORM results in shortlist place at the European Supply Chain Excellence Awards 2010

September 21, 2010 8:31 am | by RealWire | News | Comments

21 September 2010 - Human care company Elekta has been shortlisted in the European Supply Chain Excellence Awards 2010 for its "Mission Control" initiative after achieving parts availability above 99 per cent. Recognised by the judges as an innovative supply chain practice, Elekta...

TOPICS:

HealthWarehouse.com Partners with Columbia Medical Associates to Bring Affordable Healthcare to Washington State

September 21, 2010 8:31 am | by Bio-Medicine.Org | News | Comments

CINCINNATI, Sept. 21 /- HealthWarehouse.com, Inc. (OTC Bulletin Board: HEWA ), a leading retail mail-order online pharmacy and Columbia Medical Associates, an outpatient clinic system offering medical services in the Spokane, Washington metropolitan area, announced a partnership to offer...

TOPICS:

Parts Without Limits

September 21, 2010 8:19 am | by Brian Ford | Quickparts | Articles | Comments

Medical device manufacturers are constantly seeking new and better methods with which to design and manufacture medical devices. Recently, they are looking to a traditional prototype process that is enabling the fabrication of commercially ready components. This article looks at low-volume layered manufacturing.

How are you influencing medical devices related to military?

September 21, 2010 7:57 am | Omnetics Connector Corp., Emerson Network Power Connectivity Solutions | Articles | Comments

Applying Tech: How are you influencing medical devices related to military?

Volcano Drives Innovation Forward With Three New U.S. Product Launches at TCT 2010

September 21, 2010 7:32 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Sept. 21 /- Volcano Corporation (Nasdaq: VOLC ) today announced the company's plans to launch Eagle Eye® Platinum, PrimeWire PRESTIGE™, and the s5™/s5i™ 3.2.1 Software at the Transcatheter Cardiovascular Therapeutics (TCT) Meeting from September 21 - 25...

TOPICS:
Advertisement

Interdisciplinary Convergent Approach May Represent Future for Treatment of Atrial Fibrillation

September 21, 2010 7:32 am | by Bio-Medicine.Org | News | Comments

MORRISVILLE, N.C., Sept. 21 /- During the recent Atrial Fibrillation Session of the Techno College at the European Association of Cardiac Thoracic Surgeons in Geneva, Switzerland, Professor Borut Gersak, Head of Cardiac Surgery from University Medical Center in Ljubljana, Slovenia...

TOPICS:

UNC researchers identify genetic patterns that may predict osteoarthritis

September 21, 2010 6:34 am | by EurekAlert | News | Comments

(University of North Carolina School of Medicine) The study, which was part of the Johnston County Osteoarthritis Project, showed patients with X-ray evidence of knee osteoarthritis who inherited a specific pattern of genetic variations in the interleukin-1 receptor antagonist gene...

TOPICS:

Leaders trial: 3-year data on stent with biodegradable polymer to be presented at TCT 2010

September 21, 2010 6:34 am | by EurekAlert | News | Comments

(Cardiovascular Research Foundation) Three-year data from the prospective, randomized LEADERS trial demonstrate the equivalence of a biolimus A9-eluting stent with a biodegradable polymer vs. a sirolimus-eluting stent with a durable polymer. The results will be presented at the...

TOPICS:

PositiveID Corporation and Diabetes Research Institute at the University of Miami Initiate Study for the Company's GlucoChip Glucose-Sensing Microchip

September 21, 2010 6:31 am | by PositiveID | News | Comments

PositiveID Corporation and Diabetes Research Institute at the University of Miami Initiate Study for the Company's GlucoChip Glucose-Sensing Microchip

TOPICS:

Gen-Probe elects former Cytyc CEO to board

September 21, 2010 5:45 am | by The Associated Press | News | Comments

Diagnostic DNA test maker Gen-Probe Inc. said Monday that it elected former Cytyc CEO Patrick Sullivan to its board of directors.Sullivan, 58, was president and CEO of women's health product maker Cytyc from 1994 until 2007, when the company was acquired by test maker Hologic Corp. He was the...

Boston Heart Lab names new CEO, closes Series C financing

September 21, 2010 5:32 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Framingham-based Boston Heart Lab has announced its appointment of new CEO Susan Hertzberg and its closing of a $10 million Series C funding round, led by Bain Capital Ventures.

PROMUS® Element™ Stent Approved for Use in Diabetic and Heart Attack Patients in CE Mark Countries

September 21, 2010 5:31 am | by Boston Scientific | News | Comments

NATICK, Mass., Sept. 21 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced that its PROMUS® Element™ Everolimus-Eluting Coronary Stent System has received CE Mark approval for use in patients

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading